Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 263.24
-0.80 (-0.30%)
At close: Jan 9, 2026
Cochlear Market Cap
Cochlear has a market cap or net worth of 17.22 billion as of January 9, 2026. Its market cap has decreased by -11.00% in one year.
Market Cap
17.22B
Enterprise Value
17.18B
Revenue
2.34B
Ranking
n/a
PE Ratio
44.41
Stock Price
263.24
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 17.22B, an increase of 38,867.41%. That is a compound annual growth rate of 21.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 17.22B | 0.99% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.11B |
| Pro Medicus | 22.56B |
| Sonic Healthcare | 11.04B |
| Ramsay Health Care | 8.20B |
| Ansell | 4.75B |
| Telix Pharmaceuticals | 3.84B |
| Mesoblast | 3.78B |
| 4DMedical | 2.46B |